Position in INSM
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$641,639
New position
Shares Held
6,018
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#382
of 663 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cannon Advisors, Inc. holds $2,099,489 across 2 Biotechnology names. INSM ranks #2 (30.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
5,956 | $1,457,850 | |
| 2 | INSM |
INSMED Inc
This page
|
6,018 | $641,639 |
All Filings in INSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $641,639 | 6,018 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||